Thinking about offering CDHPs? Read my story first. Looking back on open enrollment last year, I can see that my choice to enroll in a high-deductible health plan – also
Can states combat rising prescription drug costs? The rising costs of prescription drugs is a high priority for patients, providers, payers, and purchasers at the state and federal levels. Kaiser
Andréa Caballero speaks with David Muhlestein, Chief Research Officer at Leavitt Partners, about his latest research titled “Growth of Population-Based Payments is Not Associated With a Decrease in Market-Level Cost
Catalyst for Payment Reform has teamed up with The Center to Advance Palliative Care (CAPC) to help make employers and other health care purchasers aware of the opportunities to get
Early findings from the Vitals for Change Scorecard, a guide for employers from Mercer and Catalyst for Payment Reform Frustration with the US health care system is mounting. There’s a
Overuse, misuse, and underuse of care are all types of inappropriate care that can result in negative patient outcomes and increased health care costs. In fact, it is estimated that
